
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents
Keywords: RESIST-HCV; Liver Cancer Risk; Reduction; Sofosbuvir; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; DAAs; direct-antiviral agents; EGS; esophageal gastroscopy; EV; esophageal varices; HCC; hepatocellular carcinoma; HCV; hepatitis C virus;